{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroControls\u2122M Linearity DROP LQ Blood Glucose"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K161874",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130762"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "July 7, 2016",
    "Summary Letter Received Date": "July 8, 2016",
    "Submission Date": "August 05, 2016",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Cobas c501"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroControls\u2122M Linearity DROP LQ Blood Glucose quality control material simulating patient samples to verify linearity, calibration, and reportable range for glucose assays",
    "Indications for Use Summary": "For in vitro diagnostic use as assayed quality control material to simulate human patient samples for determining linearity, calibration verification, and verification of reportable range for glucose analyte",
    "fda_folder": "Clinical Chemistry"
}